{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:50Z","timestamp":1786119410768,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/inf.0b013e31819bc491","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T01:22:10Z","timestamp":1264555330000},"page":"748-750","source":"Crossref","is-referenced-by-count":28,"title":["LONG-TERM LINEZOLID TREATMENT IN A YOUNG CHILD WITH EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS"],"prefix":"10.1097","volume":"28","author":[{"given":"H Simon","family":"Schaaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Willemse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Donald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210202","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1128\/AAC.47.1.416-417.2003","article-title":"In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs.","volume":"47","author":"Alcal\u00e1","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R2-21-20210202","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijantimicag.2005.03.006","article-title":"In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.","volume":"26","author":"Erturan","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"R3-21-20210202","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jac\/dki148","article-title":"Linezolid for the treatment of multidrug-resistant tuberculosis.","volume":"56","author":"Fort\u00fan","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R4-21-20210202","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jac\/dkl298","article-title":"Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.","volume":"58","author":"Park","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R5-21-20210202","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jinf.2005.04.007","article-title":"Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)\u2013a report of ten cases.","volume":"52","author":"Von der Lippe","year":"2006","journal-title":"J Infect"},{"key":"R6-21-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1378\/chest.07-1988","article-title":"Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis.","volume":"134","author":"Condos","year":"2008","journal-title":"Chest"},{"key":"R7-21-20210202","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1592\/phco.26.4.563","article-title":"Intravenous linezolid administered orally: a novel desensitization strategy.","volume":"26","author":"Cawley","year":"2006","journal-title":"Pharmacother"},{"key":"R8-21-20210202","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00006454-200209000-00018","article-title":"Use of linezolid in children.","volume":"21","author":"Kaplan","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R9-21-20210202","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1128\/AAC.39.12.2692","article-title":"Antituberculosis activity of clarithromycin.","volume":"39","author":"Luna-Herrera","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-21-20210202","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/00365540152029954","article-title":"Early bactericidal activity of amoxicillin in combination with clavulanic acid in patients with sputum smear-positive pulmonary tuberculosis.","volume":"33","author":"Donald","year":"2001","journal-title":"Scand J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e31819bc491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:14:11Z","timestamp":1786040051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200908000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31819bc491","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}